Table 1.
Demographic characteristics, concomitant comorbidities prevalence and NIMV requirement in patients with and without long COVID
| Long COVID (n = 50) | Non–long COVID (n = 50) | P value | |
|---|---|---|---|
| Age, years | 61 (51-73) | 61 (53-69) | .85 |
| Male gender, n (%) | 28 (56%) | 28 (56%) | >.99 |
| BMI at follow-up, kg/m2 | 27.5 (25-32) | 27.7 (24-31) | .63 |
| Overweight/obese, n (%) | 37 (74%) | 37 (74%) | >.99 |
| Hypertension, n (%) | 17 (34%) | 22 (44%) | .4 |
| Cardiovascular disease, n (%) | 5 (10%) | 4 (8%) | >.99 |
| Diabetes mellitus, n (%) | 3 (6%) | 5 (10%) | .71 |
| Active neoplasia, n (%) | 2 (4%) | 1 (2%) | >.99 |
| NIMV, n (%) | 14 (28%) | 15 (30%) | >.99 |
| CRP at admission, mg/dL | 73.8 (31-133) | 78.5 (29-119) | .68 |
| LDH at admission, U/L | 456 (315-584) | 411 (288-504) | .71 |
| N/L ratio at admission | 5.1 (3.3-7.2) | 4.8 (3.1-7) | .82 |
| Albumin at admission, g/L | 31 (28-37) | 32.1 (27.5-38) | .56 |
| CRP at follow-up, mg/dL | (n = 41) 4.1 (2.5-8) | (n = 36) 3.9 (2.2-6.8) | .55 |
| LDH at follow-up, U/L | (n = 18) 168 (113-235) | (n = 22) 147 (108-215) | .81 |
| N/L ratio at follow-up | 1.8 (1.4-2.1) | 1.74 (1.2-2.4) | .85 |
| Glucose levels at follow-up, mg/dL | 98.5 (92-106) | 97.5 (89-113) | .71 |
Abbreviations: BMI, body mass index; CRP, C-reactive protein; LDH, lactate dehydrogenase; NIMV, noninvasive mechanical ventilation; N/L neutrophil to lymphocyte.